STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03548935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1961

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolism and Nutrition Disorder
Overweight or Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S